Showing results (111-120 of 207) with videos related to
Sort By:
Pageof 21
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanomaMaha Ayyoub, Stefan Stevanovic, Ugur Sahin, et al.International Journal of Cancer|August 12, 2005
Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancerAxel Mischo, Boris Kubuschok, Kubilay Ertan, et al.International Journal of Cancer|January 25, 2006
Serological immune response to cancer testis antigens in patients with pancreatic cancerAndreas Wadle, Boris Kubuschok, Jochen Imig, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory studyDieter Kube, Thanh-Duc Hua, Frederike von Bonin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphomaGerhard Held, Niels Murawski, Marita Ziepert, et al.Blood|July 28, 2011
Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2AKlaus-Dieter Preuss, Michael Pfreundschuh, Natalie Fadle, et al.The Lancet. Oncology|May 16, 2014
Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trialBertram Glass, Justin Hasenkamp, Gerald Wulf, et al.International Journal of Cancer|January 21, 2014
Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MMCarsten Zwick, Gerhard Held, Michaela Auth, et al.Plos One|March 14, 2013
Serum antibodies against CD28-- a new potential marker of dismal prognosis in melanoma patientsRebecca Körner, Klaus-Dieter Preuss, Natalie Fadle, et al.Clinical Chemistry and Laboratory Medicine|September 12, 2009
Detection of Meningeosis neoplastica by real-time quantitation of telomerase activityGunter Assmann, Christian Werner, Markus Herrmann, et al.Pageof 21